| Literature DB >> 36034003 |
François Mbonyinshuti1,2, Joseph Nkurunziza3, Japhet Niyobuhungiro4, Egide Kayitare5.
Abstract
Introduction: recent initiatives in healthcare reform have pushed for a better understanding of data complexity and revolution. Given the global prevalence of Non-Communicable Diseases (NCD) and the economic and clinical burden they impose, it is recommended that the management of essential medicines used to treat them be renovated and optimized through the application of predictive modeling such a RF model.Entities:
Keywords: Non-communicable diseases; essential medicines; machine learning; random forest
Mesh:
Substances:
Year: 2022 PMID: 36034003 PMCID: PMC9379432 DOI: 10.11604/pamj.2022.42.89.33833
Source DB: PubMed Journal: Pan Afr Med J
categorization of selected essential medicines
| ATC code | NCD´s essential medicines | Pharmacotherapeutic Group |
|---|---|---|
|
| Captopril 25 mg tablet | Angiotensin-converting enzyme (ACE) inhibitors |
|
| Aminophylline 100mg tablet | Bronchodilator consisting of theophylline |
|
| Prednisolone 5 mg tablet | Corticosteroids |
|
| Salbutamol 4mg tablet | Selective beta-2-adrenoreceptor agonists |
|
| Glibenclamide 5 mg tablet | Oral hypoglycemic agents which is a Sulfonyl urea derivative |
|
| Furosemide 40 mg tablet | High-ceiling diuretic sulfonamides, loop diuretics |
|
| Hydrochlorothiazide 50mg tablet | Thiazide diuretic |
|
| Nifedipine 20 mg tablet | Calcium channel blocker with vascular effects (dihydropyridine derivative) |
|
| Spironolactone 25 mg tablet | Potassium-sparing Agents |
|
| Metformin 500 mg tablet | Blood glucose lowering drugs. Biguanide oral hypoglycemic agents |
|
| Ephedrine 50mg/ml injection | Adrenergic and dopaminergic agents |
|
| Insulin human 100ui/ml injection (Humulin® 100 IU/ml) | Insulins and analogues for injection, intermediate-acting |
|
| Tamoxifen citrate 20mg tablet | Anti-estrogens |
|
| Morphine 10 mg/ml injection | Opioids, natural opium alkaloids |
|
| Allopurinol 100mg tablet | Antigout preparations inhibiting uric acid production |
|
| Beclomethasone 250mcg cfc | Glucocorticoid |
|
| Enalapril 5 mg tablet | Angiotensin converting enzyme (ACE) inhibitor |
Figure 1description of RF model
consumption of essential medicines for NCDs by quantity and frequency (2015-2019)
| # | Name of Essential Medicines | Quantity | Frequency |
|---|---|---|---|
|
| Aminophylline 100mg tablet b/1000 | 26,839,457 | 19,475 |
|
| Salbutamol 4mg tablet b/1000 | 25,753,669 | 17,178 |
|
| Prednisolone 5 mg tablet b/1000 | 23,598,175 | 17,091 |
|
| Captopril 25 mg tablet b/100 | 15,140,860 | 9,446 |
|
| Furosemide 40 mg tablet b/1000 | 13,464,774 | 7,873 |
|
| Glibenclamide 5 mg tablet b/1000 | 11,641,185 | 6,786 |
|
| Insulin hum 100ui/ml Lente inj b/1 | 5,756,901 | 3,705 |
|
| Hydrochlorothiazide 50mg tablet b/1000 | 3,435,412 | 2,910 |
|
| Spironolactone 25 mg tablet b/100 | 2,348,623 | 2,626 |
|
| Ephedrine 50mg/ml injection b/100 | 553,424 | 2,439 |
|
| Beclomethasone 250mcg cfc/vial | 107,040 | 2,366 |
|
| Morphine 10 mg/ml injection b/100 | 95,178 | 1,086 |
|
| Nifedipine 20 mg tablet b/1 | 81,422 | 786 |
|
| Metformin 500 mg tablet b/28 | 53,250 | 374 |
|
| Allopurinol 100mg tablet b/1 | 33,780 | 94 |
|
| Tamoxifen citrate 20mg tablet b/1 | 32,381 | 84 |
|
| Enalapril 5 mg tablet b/28 | 21,824 | 40 |
Figure 2A) the trend of quantity consumed for all combined NCD essential medicines; B) the trend of quantity consumed for each individual NCD essential medicines
Figure 3mapping the consumption of NCD essential medicines stratified by district
summary statistics on the amount of NCD essential medicines consumed by the training and testing groups
| Set | Variable | Count | Mean | SD* | Median | Min | Max |
|---|---|---|---|---|---|---|---|
|
| Amount | 73,066.00 | 992.76 | 1,370.16 | 495.00 | 4.00 | 8,200.00 |
| Grouped/Total Amount | 11,659 | 6,208.58 | 7,241.64 | 3,765.00 | 4.00 | 8,186.00 | |
|
| Amount | 28,680.00 | 1,069.83 | 1,387.78 | 570.00 | 4.00 | 5,602.00 |
| Grouped/Total Amount | 3,733.00 | 8,187.30 | 8,931.23 | 5,602.00 | 4.00 | 57,568.00 |
*SD= Standard deviation
presentation of random forest model experimental results
| Model | Set | RMSE | R-square |
|---|---|---|---|
|
| Train | 1.137 | 0.78 |
| Test | 1.23 | 0.71 |
Figure 4the use RF model for prediction of NCD essential medicines demand (projected needs) versus actual consumed quantity on monthly basis